US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

243.09

+20.099.01%

Post-market: 242.00-1.0900-0.45%18:54 EDT

Volume:607.08K

Turnover:144.76M

Market Cap:637.99M

PE:- -

High:246.22

Open:223.71

Low:222.45

Close:223.00

52wk High:341.93

52wk Low:102.35

Shares:2.62M

Float Shares:2.62M

Volume Ratio:1.01

T/O Rate:23.13%

Dividend:0.91

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Healthcare Stocks Declined as Consumer Confidence Slips

Health Care Roundup: Market Talk

Max Healthcare updates on adjourned NCLT case involving Kalinga Hospital subsidiary

Neogen selloff after FDA warning letter ‘overdone,’ says Guggenheim

Neogen issued FDA warning letter for Neogen Vet HYCOAT

Analyst Gil Blum Lifts Immix Biopharma Price Target to $30 on Strong NEXICART-2 Data and Accelerated Commercial Path

Analysts Are Bullish on Top Healthcare Stocks: Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS)

Health Care Roundup: Market Talk

Neogen Gets FDA Warning After Probe Links Vet Product to Horse Deaths

Fidia delays approval of half-year 2026 results to complete audit work

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sector Update: Healthcare Stocks Advance Pre-Bell Tuesday

MT Newswires Live

GPI Boosts Profitability and Foreign Growth on High-Margin Healthcare Software

Health Care Select Sector SPDR: Pivot points

Cognition Therapeutics schedules Type C meeting with FDA for trial of CT1812

Aldeyra to submit Formal Dispute Resolution Request to FDA for reproxalap

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

BeyondSpring announces U.S. FDA granted Fast Track designation to Plinabulin

SI-Bone (SIBN) Gets a Buy from Canaccord Genuity

Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Adagene (ADAG) and Inventiva (IVA)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LABU/news?page=17"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":243.09,"timestamp":1791576000000,"preClose":223,"halted":0,"volume":607080,"hourTrading":{"tag":"盘后","latestPrice":242,"preClose":243.09,"latestTime":"18:54 EDT","volume":1904,"amount":461729.34864,"timestamp":1791586456091,"change":-1.09,"changeRate":-0.004484,"amplitude":0.004484},"delay":0,"changeRate":0.09008968609865473,"floatShares":2624500,"shares":2624500,"eps":0,"marketStatus":"Post-Mkt","change":20.09,"latestTime":"10-09 19:01:48 EDT","open":223.71,"high":246.22,"low":222.45,"amount":144763404.3924,"amplitude":0.106592,"askPrice":247.8,"askSize":200,"bidPrice":242,"bidSize":75,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":223,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.003761,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":223.28,"preClose":223,"latestTime":"09:28 EDT","volume":2212,"amount":498293.87776,"timestamp":1791552512789,"change":0.28,"changeRate":0.001256,"amplitude":0.01487},"postHourTrading":{"tag":"盘后","latestPrice":242,"preClose":243.09,"latestTime":"18:54 EDT","volume":1904,"amount":461729.34864,"timestamp":1791586456091,"change":-1.09,"changeRate":-0.004484,"amplitude":0.004484},"volumeRatio":1.01266,"impliedVol":0.9666,"impliedVolPercentile":0.7052},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2624500,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.01266,"shares":2624500,"dividePrice":0.9143,"high":246.22,"amplitude":0.106592,"preClose":223,"low":222.45,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":243.09,"committee":-0.454545,"eps":0,"divideRate":0.003761,"volume":607080,"delay":0,"ttmEps":0,"open":223.71,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":248.72,"twentyDayClose":261.3,"sixtyDayClose":254.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:17,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671247293","title":"Healthcare Stocks Declined as Consumer Confidence Slips","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247293","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247293?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:58","pubTimestamp":1790715480,"startTime":"0","endTime":"0","summary":"On a losing day in Wall Street, the healthcare industry was no exemption. Stocks fell amid a surprising decline in the Conference Board Consumer Confidence Index.UniQure slid after patients treated with its Huntington's disease drug in a recent study no longer showed a statistically significant slowdown in disease-induced decline after four years. At four years, the study's primary endpoint--composite Unified Huntington's Disease Rating Scale --showed a 44% slowing of disease progression compared with an external control, but the data did not reach statistical significance, the company said.Novo Nordisk has signed a licensing deal for a weight-loss treatment being developed by Hengrui Pharma that could be worth up to $2.6 billion. The Danish drugmaker will pay China-based Hengrui $300 million upfront, with the rest of the potential deal value tied to milestones. Novo will obtain exclusive rights to develop, manufacture and commercialize HRS-1596 globally, excluding mainland China, Hong","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4588","XLV","LU0128526141.USD","HCSG","BK4137","BK4585","XBI","LABU","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671247428","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247428","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247428?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:50","pubTimestamp":1790715000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1019 ET - Sterling shows little reaction after U.K. Prime Minist","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LABU","XLV","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671241431","title":"Max Healthcare updates on adjourned NCLT case involving Kalinga Hospital subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2671241431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671241431?lang=en_us&edition=fundamental","pubTime":"2026-09-30 02:03","pubTimestamp":1790705014,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Max Healthcare Institute Ltd ( ($IN:MAXHEALTH) ). Max Healthcare Institute Ltd has updated exchanges on ongoing...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/max-healthcare-updates-on-adjourned-nclt-case-involving-kalinga-hospital-subsidiary?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/max-healthcare-updates-on-adjourned-nclt-case-involving-kalinga-hospital-subsidiary?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4137","HCSG","BK4585","LU0128526141.USD","XBI","LABU","XLV","LU0029874061.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671324954","title":"Neogen selloff after FDA warning letter ‘overdone,’ says Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2671324954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671324954?lang=en_us&edition=fundamental","pubTime":"2026-09-30 01:15","pubTimestamp":1790702111,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Subbu Nambi notes that Neogen (NEOG) shares sold off after the FDA issued warning letter related to Neogen Vet HYCOAT for veteri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neogen-selloff-after-fda-warning-letter-overdone-says-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neogen-selloff-after-fda-warning-letter-overdone-says-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","PJP","NEOG","BK4585","LU2211817866.USD","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671249510","title":"Neogen issued FDA warning letter for Neogen Vet HYCOAT","url":"https://stock-news.laohu8.com/highlight/detail?id=2671249510","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671249510?lang=en_us&edition=fundamental","pubTime":"2026-09-30 01:10","pubTimestamp":1790701811,"startTime":"0","endTime":"0","summary":"The FDA posted a warning letter, dated September 23, to its site earlier that states in part: “This Warning Letter summarizes significant violation...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neogen-issued-fda-warning-letter-for-neogen-vet-hycoat-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neogen-issued-fda-warning-letter-for-neogen-vet-hycoat-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671246794","title":"Analyst Gil Blum Lifts Immix Biopharma Price Target to $30 on Strong NEXICART-2 Data and Accelerated Commercial Path","url":"https://stock-news.laohu8.com/highlight/detail?id=2671246794","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671246794?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:55","pubTimestamp":1790700918,"startTime":"0","endTime":"0","summary":"Immix Biopharma, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum from Needham reiterated a Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-gil-blum-lifts-immix-biopharma-price-target-to-30-on-strong-nexicart-2-data-and-accelerated-commercial-path-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-gil-blum-lifts-immix-biopharma-price-target-to-30-on-strong-nexicart-2-data-and-accelerated-commercial-path-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4585","LABU","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671743246","title":"Analysts Are Bullish on Top Healthcare Stocks: Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671743246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671743246?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:40","pubTimestamp":1790700010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS) a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-invivyd-ivvd-newamsterdam-pharma-company-nams-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-invivyd-ivvd-newamsterdam-pharma-company-nams-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","BK4588","BK4539","XLV","XBI","NAMS","BK4585","BK4139","LABU","LU0029874061.USD","IVVD","BK4137","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671246586","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2671246586","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671246586?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:20","pubTimestamp":1790698800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1019 ET - Sterling shows little reaction after U.K. Prime Minist","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","XBI","XLV","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671924571","title":"Neogen Gets FDA Warning After Probe Links Vet Product to Horse Deaths","url":"https://stock-news.laohu8.com/highlight/detail?id=2671924571","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671924571?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:06","pubTimestamp":1790697960,"startTime":"0","endTime":"0","summary":"Neogen received warning letters from the Food and Drug Administration following an investigation that linked a vet wound care product labeled as sterile to serious infections and deaths in horses.The ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4198","BK4585","LU2211817866.USD","NEOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671248865","title":"Fidia delays approval of half-year 2026 results to complete audit work","url":"https://stock-news.laohu8.com/highlight/detail?id=2671248865","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671248865?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:03","pubTimestamp":1790690596,"startTime":"0","endTime":"0","summary":"Fidia Spa ( ($IT:FDA) ) just unveiled an update. Fidia S.p.A. has postponed the approval of its half-year financial report as of 30 June 2026, resc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fidia-delays-approval-of-half-year-2026-results-to-complete-audit-work?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fidia-delays-approval-of-half-year-2026-results-to-complete-audit-work?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VGT","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671217785","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2671217785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671217785?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:30","pubTimestamp":1790688638,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Summit Therapeutics (SMMT) and Zymeworks (ZYME) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-361?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-361?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","BK4588","XLV","LU2488822045.USD","XBI","BK4585","BK4139","SMMT","ZYME","LU0029874061.USD","LABU","BK4137","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671176842","title":"Sector Update: Healthcare Stocks Advance Pre-Bell Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2671176842","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671176842?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:24","pubTimestamp":1790688276,"startTime":"0","endTime":"0","summary":"Healthcare stocks were advancing pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF  up 0.1% and the iShares Biotechnology ETF  0.3% higher.Iovance Biotherapeutics  stock was up more than 18% after the company raised its full year 2026 total revenue guidance to a range of $410 million to $420 million, from its prior outlook of $350 million to $370 million.UniQure  shares were down more than 47% after the company said additional data from its ongoing phase 1/2 studies of AMT-130 in Huntington's disease showed less pronounced benefits at 48 months.Pharming Group  has appointed chief commercial officer Leverne Marsh and chief financial officer Kenneth Lynard as interim co-chief executive officers, the company said. Pharming Group stock was down more than 3% pre-bell.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","LU0029874061.USD","BK4137","LABU","LU0320765992.SGD","IOVA","BK4585","LU0889565916.HKD","QURE","XLV","BK4139","PHAR","LU0128526141.USD","BK4581","HCSG","IBB","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671121562","title":"GPI Boosts Profitability and Foreign Growth on High-Margin Healthcare Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2671121562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671121562?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:53","pubTimestamp":1790686381,"startTime":"0","endTime":"0","summary":"GPI SpA ( ($IT:GPI) ) has shared an announcement. GPI SpA reported first-half 2026 revenues of €256.4 million, broadly stable year on year, as grow...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gpi-boosts-profitability-and-foreign-growth-on-high-margin-healthcare-software?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gpi-boosts-profitability-and-foreign-growth-on-high-margin-healthcare-software?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VGT","LU0128526141.USD","XBI","BK4588","XLV","LABU","GPI","LU0029874061.USD","BK4581","HCSG","BK4214","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671231214","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2671231214","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671231214?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:38","pubTimestamp":1790685496,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $172.71, Pivot Low: $170.42. These were calculated usi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-152?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-152?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4588","LABU","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671219930","title":"Cognition Therapeutics schedules Type C meeting with FDA for trial of CT1812","url":"https://stock-news.laohu8.com/highlight/detail?id=2671219930","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671219930?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:36","pubTimestamp":1790681804,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) announced that a Type C meeting with the U.S. Food and Drug Administration, FDA, Division of Neurology has been sched...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-schedules-type-c-meeting-with-fda-for-trial-of-ct1812-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-schedules-type-c-meeting-with-fda-for-trial-of-ct1812-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4007","CGTX","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671268216","title":"Aldeyra to submit Formal Dispute Resolution Request to FDA for reproxalap","url":"https://stock-news.laohu8.com/highlight/detail?id=2671268216","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671268216?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680247,"startTime":"0","endTime":"0","summary":"Aldeyra (ALDX) Therapeutics announced intent to submit to the U.S. Food and Drug Administration a Formal Dispute Resolution Request for reproxalap,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aldeyra-to-submit-formal-dispute-resolution-request-to-fda-for-reproxalap-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aldeyra-to-submit-formal-dispute-resolution-request-to-fda-for-reproxalap-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","ALDX","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216266","title":"Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216266?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680206,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Summit Therapeutics (SMMT), Ocular Therapeutix (OC...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","REGN","LU2362541513.USD","LU0128526141.USD","LABU","BK4139","LU2023250504.SGD","SMMT","TBXU","LU2362540622.SGD","LU2089984988.USD","OCUL","BK4581","LU0889565916.HKD","LU0320765992.SGD","LU2362541273.HKD","LU0289739699.SGD","BK4007","LU2106854487.HKD","XLV","BK4137","LU1974910355.USD","LU2488822045.USD","IBB","LU0029874061.USD","LU1917777945.USD","LU0109394709.USD","BBH","XBI","LU2237438978.USD","LU0114720955.EUR","BK4588","LU2468319806.SGD","HCSG","LU0823434740.USD","LU0882574055.USD","LU0058720904.USD","LU0823416689.USD","LU0053666078.USD","IBBQ","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216480","title":"BeyondSpring announces U.S. FDA granted Fast Track designation to Plinabulin","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216480","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216480?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679952,"startTime":"0","endTime":"0","summary":"BeyondSpring (BYSI) announced that the U.S. Food and Drug Administration, FDA, has granted Fast Track designation to Plinabulin and docetaxel for t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beyondspring-announces-u-s-fda-granted-fast-track-designation-to-plinabulin-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beyondspring-announces-u-s-fda-granted-fast-track-designation-to-plinabulin-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4588","LABU","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215009","title":"SI-Bone (SIBN) Gets a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215009?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:56","pubTimestamp":1790679373,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Caitlin Roberts reiterated a Buy rating on SI-Bone today and set a price target of $27.00. Roberts covers the Healthcare ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/si-bone-sibn-gets-a-buy-from-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/si-bone-sibn-gets-a-buy-from-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","SIBN","BK4082","LABU","BK4581","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671168852","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Adagene (ADAG) and Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671168852","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671168852?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:50","pubTimestamp":1790679012,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF), Adagene (ADAG) and Inven...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-adagene-adag-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-adagene-adag-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2293690082.USD","BK4139","BK4585","BK4581","LU2539964713.USD","BK4588","LU0029874061.USD","HCSG","LABU","LU1046234339.USD","ADAG","BK4137","RHHVF","LU0128526141.USD","LU2293690249.USD","BK4007","XLV","XBI","IVA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":17,"totalSize":417,"code":"91000000","status":"200"}]}}